59th Medical Wing

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, 59th Medical Wing sits in the top decile of US sponsors by registered trial count (#743 of 15,742 sponsors by registered trial count).

20 total trials 3 currently recruiting 14 completed later-stage tilt top decile by trial count

59th Medical Wing: 20 sponsored US clinical trials, 3 recruiting.

59th Medical Wing sponsors 20 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 14 completed. 4 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Astigmatism, with 2 trials.

Top-decile sponsor footprint

59th Medical Wing ranks in the top decile of sponsors by registered trial count (#743 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 73/100

14 of 15 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

20 total, page 1 of 1

RECRUITING NA

Evaluation of a Device to Reduce Motion Sickness and Spatial Disorientation

NCT06892340

RECRUITING NA

Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial

NCT05844384

RECRUITING NA

CONTOURA vs WFO Ablation PRK & LASIK

NCT05037370

ACTIVE NOT RECRUITING NA

LASIK iDesign vs SMILE

NCT07126756

ACTIVE NOT RECRUITING NA

LASIK Using Contoura With Phorcides vs. iDesign

NCT07128316

COMPLETED NA

Characterizing the Effects of Platelet-Rich Fibrin (PRF) as a Palatal Wound Dressing on Quality of Life and Sleep Following Mucogingival Surgery. Study Was Conducted at the Air Force Post Graduate Dental School. All HIPPA Consents and Research Informed Consents Are Located at JBSA-Lackland.

NCT07637838

COMPLETED NA

SMILE vs. LASIK Using Contoura With Phorcides

NCT05844397

COMPLETED NA

Dry Needling for Sub Acromial Pain Syndrome

NCT03442894

COMPLETED Phase 4

Post-operative Pain Control After Photorefractive Keratectomy Comparing Acetaminophen/Codeine vs Acetaminophen/Oxycodone

NCT04399122

COMPLETED NA

Impact of a Diabetes Risk Score on Lifestyle Education and Patient Adherence

NCT01932866

COMPLETED NA

A Comparison of Pregabalin (Lyrica®) to Placebo in Pain Relief After Photorefractive Keratectomy (PRK) Surgery

NCT01097577

TERMINATED NA

Sleeve Gastrectomy Versus Medical Management for Remission of Diabetes in Mild to Moderately Obese Patients

NCT00965302

COMPLETED

Military Women's Health and Illness Behaviors in Deployed Settings

NCT00815074

COMPLETED NA

Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection

NCT00822692

COMPLETED NA

Trial of Antibiotic Treatment for Skin Abscess in Patients at Risk for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection

NCT00829686

COMPLETED Phase 4

Does Allopurinol Prolong a Treated, Acute Gout Flare?

NCT01988402

COMPLETED Phase 3

Prospective Randomized Trial of Bactrim on 7 Day Outcome in Patients With Uncomplicated Abscesses

NCT00973765

COMPLETED

Levels of Serum Resistin in Asthmatics as a Potential Marker of Systemic Inflammation and Disease State.

NCT00339703

COMPLETED Phase 2

Intracervical Block Versus Placebo to Assess Pain Control During Hysterosalpingogram

NCT00372658

COMPLETED Phase 3

The Effect of Metformin Added to Clomiphene Citrate on Pregnancy Rates in Hyperandrogenic, Chronic Oligoovulatory or Anovulatory Women

NCT00413179

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 2
Phase 4 2

Where 59th Medical Wing enrollment is open (later-stage tilt)

3 recruiting of 20 indexed (15% open); 14 completed (70%).

Phase mix: 4 late (III/IV) vs 1 early (I/II) (later-stage heavy).

Top condition: Astigmatism (2 trials), 7 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

59th Medical Wing: open-pipeline peers nationwide

Peers matched on 20 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

59th Medical Wing sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 050100150200250 0%5%10%15%20% Total trials Recruiting share 59th Medical WingAbiomedAgency for Healthcare Research and Quality (AHRQ)Alliance Foundation TrialsApplied Science & Performance InstituteHoag Memorial Hospital PresbyterianMedtronic Neurovascular Clinical AffairsVivek ReddyGeorgetown University
59th Medical Wing sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

59th Medical Wing sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 20 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this 59th Medical Wing page

20 registered trials is a research-attention snapshot, not an endorsement of 59th Medical Wing or any single study.

  • 3 of 59th Medical Wing's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Astigmatism is the condition 59th Medical Wing studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Astigmatism trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

59th Medical Wing pipeline card: 20 registered trials from official public datasets.Report a data error.